Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Effect of antiresorptive therapy on urinary hydroxyproline in postmenopausal osteoporosis.

Jagtap VR, Ganu JV.

Indian J Clin Biochem. 2012 Jan;27(1):90-3. doi: 10.1007/s12291-011-0185-4. Epub 2011 Dec 25.

2.
4.

Hospital based preliminary study on osteoporosis in postmenopausal women.

Indumati V, Patil VS, Jailkhani R.

Indian J Clin Biochem. 2007 Sep;22(2):96-100. doi: 10.1007/BF02913323.

6.

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD.

J Bone Miner Res. 2000 Aug;15(8):1526-36.

7.
8.

The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study.

Ceballos A, Mas R, Castaño G, Fernández L, Mendoza S, Menéndez R, González JJ, Illnait J, Gámez R, Mesa M, Fernández J.

Int J Clin Pharmacol Res. 2005;25(4):175-86.

PMID:
16402634
9.

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

Seibel MJ, Naganathan V, Barton I, Grauer A.

J Bone Miner Res. 2004 Feb;19(2):323-9. Epub 2003 Dec 16.

10.

Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.

Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R.

J Bone Miner Res. 1993 Jul;8(7):881-9.

PMID:
8352070
12.

Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.

Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.

J Bone Miner Res. 2008 May;23(5):721-9.

13.

BMD and Serum Intact Osteocalcin in Postmenopausal Osteoporosis Women.

Jagtap VR, Ganu JV, Nagane NS.

Indian J Clin Biochem. 2011 Jan;26(1):70-3. doi: 10.1007/s12291-010-0074-2. Epub 2010 Sep 14.

14.

Study of some common biochemical bone turnover markers in postmenopausal women.

Sachdeva A, Seth S, Khosla AH, Sachdeva S.

Indian J Clin Biochem. 2005 Jan;20(1):131-4. doi: 10.1007/BF02893058.

16.

[Effects of hormone replacement therapy in bone resorption, in post-menopausal women].

Villaseca P, Arteaga E, Campusano C, López JM, Rojas A, Nazar G, O'Brien A.

Rev Med Chil. 1996 Dec;124(12):1439-46. Spanish.

PMID:
9334477
17.
18.
19.

Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis.

Parviainen MT, Jääskeläinen K, Kröger H, Arnala I, Alhava E.

Clin Chim Acta. 1999 Jan;279(1-2):145-54.

PMID:
10064126
20.

Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis.

Horowitz M, Wishart JM, Need AG, Morris HA, Nordin BE.

Clin Endocrinol (Oxf). 1993 Dec;39(6):649-55.

PMID:
8287582

Supplemental Content

Support Center